Total planned funding: $530,012,341
Clear active filters
Ethiopia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Ethiopia | $530,012,341 |
Organizational Types
Unknown | $124,312,056 |
Private Contractor | $94,244,423 |
Host Country Government Agency | $80,621,525 |
NGO | $70,913,178 |
University | $46,757,157 |
Own Agency | $46,595,945 |
Implementing Agency | $45,118,328 |
Multi-lateral Agency | $13,371,784 |
Other USG Agency | $5,150,000 |
FBO | $2,927,945 |
Program Areas
Treatment | $163,482,184 |
Care | $127,927,661 |
Prevention | $104,006,094 |
Governance and Systems | $70,010,125 |
Testing | $34,769,864 |
Management and Operations | $29,816,413 |
Budget Codes
HTXS: Treatment: Adult Treatment | $149,468,972 |
HVOP: Sexual Prevention: Other Sexual Prevention | $55,384,390 |
HBHC: Care: Adult Care and Support | $54,251,538 |
HKID: Care: Orphans and Vulnerable Children | $47,791,815 |
HVCT: Testing: HIV Testing and Counseling | $34,769,864 |
OHSS: Health Systems Strengthening | $33,259,218 |
HVMS: Management and Operations | $29,816,413 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $27,767,980 |
HVSI: Strategic Information | $21,674,802 |
HLAB: Laboratory Infrastructure | $15,076,105 |
HVTB: Care: TB/HIV | $14,421,923 |
PDCS: Care: Pediatric Care and Support | $11,462,385 |
PDTX: Treatment: Pediatric Treatment | $10,206,286 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,719,562 |
HMIN: Biomedical Prevention: Injection Safety | $7,179,002 |
HTXD: Treatment: ARV Drugs | $3,806,926 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,585,367 |
HMBL: Biomedical Prevention: Blood Safety | $2,369,793 |
Top Partner Programs
Not Available:
$112,038,532
Countries/Regions
Columbia University:
$35,520,921
Countries/Regions
Chemonics International:
$31,821,296
Countries/Regions